QuidelOrtho Maintenance and Reagents
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Centers for Disease Control and Prevention (CDC), Office of Acquisition Services, intends to award a sole source, firm-fixed-price purchase order to QuidelOrtho Corporation for urgent maintenance and OEM support services for VITROS 3600 systems. This procurement, valued below the Simplified Acquisition Threshold (SAT), is for the Division of Viral Hepatitis Laboratory Branch at CDC in Atlanta, GA. Responses from interested parties are due by January 26, 2026.
Scope of Work
This requirement covers essential services for the proprietary VITROS 3600 systems, including:
- Annual Preventive Maintenance: Ensuring system reliability and performance.
- Field Application Support: On-site assistance and expertise.
- Software and Hardware Updates: Keeping systems current with the latest technology.
- Technical Support: Email and phone support available during business hours (Mon-Fri).
- Repairs and Replacements: Covering all labor and parts for instrument failures.
Contract & Timeline
- Type: Sole Source, Firm-Fixed-Price Purchase Order (RFQ 75D30126Q78789)
- Authority: FAR 13.106-1(b)(1)(i) (Simplified Acquisition Procedures)
- Set-Aside: Not applicable (Sole Source)
- NAICS: 325413 (In-Vitro Diagnostic Substance Manufacturing)
- Response Due: January 26, 2026, 12:00 PM EST
- Published: January 16, 2026
Justification for Sole Source
QuidelOrtho Corporation is identified as the Original Equipment Manufacturer (OEM) and the only known source possessing the proprietary reagents, diagnostics, and service infrastructure required to support the VITROS 3600 model equipment system according to manufacturer specifications.
Response Information
This is a combined synopsis/solicitation. While the CDC intends to award to QuidelOrtho, interested entities capable of meeting this requirement may identify their interest and capabilities. This notice is not a request for competitive quotations; however, all responses received within fifteen (15) days of the notice's issuance will be considered. A determination by the government not to compete this proposed contract is solely at their discretion. Responses should be emailed to Gary Morgan at gmorgan1@cdc.gov.